aids medicine price
The company that hiked the price of Daraprim, a drug used to treat AIDS patients, is backing off. Pharmaceutical company Turing increased the price of a drug called Daraprim from $13.50 to $750 a pill and its CEO, Martin Shkreli, quickly became the focus of public anger. The over 4,000% increase also caught the eye of Hillary Clinton. Via Twitter. The former hedge fund manager whose pharmaceutical company has come under withering attack for allegations of egregious price-gouging on life-saving medication is the subject of a $65 million lawsuit by his former employer for alleged stock manipulation—and it turns out he once tried a similar price hike scheme with that company. The price of Daraprim, a 62-year-old medical treatment used by AIDS patients, has increased by more than 5,000 percent after being acquired by pharmaceutical company Turing Pharmaceuticals for $55 million on August 10. Since Turing’s acquisition, the medication has changed from $13.50 per tablet to $750 per tablet. Martin Shkreli, 32, founder and chief executive of Turing Pharmaceuticals, changed the price of Daraprim, which is used to treat AIDS patients, from $13.50 per tablet to $750. Turing Pharmaceuticals purchased the rights to the drug in August for $55million. Scroll down for videos. 1  Martin Shkreli, 32, founder and chief executive of Turing Pharmaceuticals, changed the price of Daraprim, which is used to treat AIDS patients, from $13.50 per tablet to $750. 2  Turing Pharmaceuticals purchased the rights to the drug in August for $55million. Martin Shkreli’s current company, Turing Pharmaceuticals, has been criticized by Democratic presidential candidates Hillary Clinton and Bernie Sanders for spiking the price of a 62-year-old drug called Daraprim now used to treat AIDS patients. U.S. pharmaceutical company raises price of AIDS medication by 5,000 percent. A medication used to treat patients with compromised immune systems has increased by 5,000 percent, limiting the ability of patients to seek the treatment. Meet the most despised man in the world: Global outrage as 32-year-old ex-hedge funder buys rights to AIDS drug and promptly raises price overnight by 5500% - from $13.50 to $750.00 per pill. 1  Martin Shkreli, 32, founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim in August for $55million. Former Turing Pharmaceuticals CEO Martin Shkreli has returned to live-streaming following his arrest last week. A listener asked him why he jacked the price of AIDS drug Daraprim by 5400%. In September, Shkreli, a former hedge fund manager, hiked the price of the drug, used to help (among others) AIDS patients with compromised immune systems, from $13.50 a tablet to $750 per tablet. US pharmaceutical company defends 5,000% price increase. Read more about sharing. The head of a US pharmaceutical company has defended his company's decision to raise the price of a 62-year-old medication used by Aids patients by over 5,000%. Turing Pharmaceuticals acquired the rights to Daraprim in August.
$750 per tablet of Daraprim.